Pharmaceutical Products Companies By One Year Return

One Year Return
One Year ReturnEfficiencyMarket RiskExp Return
1MNPR Monopar Therapeutics
1.09 K
 0.14 
 8.23 
 1.19 
2DMAC DiaMedica Therapeutics
39.93
(0.12)
 3.93 
(0.47)
3MDGL Madrigal Pharmaceuticals
28.2
 0.04 
 4.30 
 0.17 
4MOLN Molecular Partners AG
17.01
(0.01)
 4.33 
(0.05)
5MLYS Mineralys Therapeutics, Common
12.51
 0.07 
 7.40 
 0.50 
6DVAX Dynavax Technologies
8.74
 0.08 
 1.50 
 0.12 
7RADX Radiopharm Theranostics Limited
7BHST BioHarvest Sciences Common
7EPRX Eupraxia Pharmaceuticals Common
7MBIO Mustang Bio
0.0
(0.30)
 9.10 
(2.69)
8MBOT Microbot Medical
0.0
 0.08 
 14.29 
 1.15 
9MBRX Moleculin Biotech
0.0
 0.04 
 29.00 
 1.30 
10MCRB Seres Therapeutics
0.0
(0.02)
 5.21 
(0.10)
11037411AR6 APACHE P 6
0.0
 0.08 
 1.72 
 0.14 
12MDCX Medicus Pharma Ltd
0.0
 0.09 
 8.49 
 0.75 
13EQ Equillium
0.0
(0.08)
 7.94 
(0.65)
14ME 23Andme Holding Co
0.0
(0.15)
 11.99 
(1.83)
15MDWD Mediwound
0.0
(0.03)
 3.71 
(0.12)
16MEIP MEI Pharma
0.0
(0.03)
 1.92 
(0.05)
17MESO Mesoblast
0.0
(0.23)
 3.76 
(0.86)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
One Year Return is the annualized return generated from holding a security for exactly 12 months. The measure is considered to be good short-term measures of fund performance. In other words, it represents the capital appreciation of fund investments over the last year. However when the market is volatile such as in recent years, One Year Return measure can be misleading. Although One Year Fund Return indicator can give a sense of overall fund short-term potential, it is recommended to look at mid and long term return measure before selecting a particular fund or ETF. The great way to validate fund short-term performance is to compare it with other similar funds or ETFs for the same 12 months interval.